SV Health Investors
28 State StreetBoston, MA 2109
Website: svhealthinvestors.com
Firm Size
- Assets Under Management (AUM):$962 Million
- Number of Funds:13
- Employees:22
- Firm Type:Venture Capital
- Focus Areas:
Software & Technology
Healthcare
Description
SV Health Investors, LLC is a prominent healthcare and life sciences investment firm based in Boston, Massachusetts. With rich expertise and experience in the industry, the company primarily focuses on identifying and supporting early-stage ventures in the field of healthcare innovation. SV Health Investors has a proven track record of successful investments in a wide array of healthcare sectors, including biopharmaceuticals, medical devices, diagnostics, and digital health. They aim to drive transformative change in the global healthcare industry by providing strategic investment, deep industry knowledge, and strong operational support to their portfolio companies. The firm's investment strategy revolves around identifying promising startups and helping them achieve their full potential. They provide financial backing, strategic guidance, and operational expertise to nurture innovative technologies and transform them into successful, market-leading enterprises. SV Health Investors prides itself on its extensive network of relationships with leading healthcare professionals, academic institutions, and industry experts. This network enables them to gain invaluable insights and access to cutting-edge research, technology, and market opportunities. Their team comprises experienced professionals with diverse backgrounds in investment, healthcare, and life sciences. By combining their collective expertise, SV Health Investors aims to achieve measurable impact, generate superior returns, and contribute to the advancement of healthcare breakthroughs. In summary, SV Health Investors, LLC is a leading healthcare and life sciences investment firm based in Boston, Massachusetts. They focus on early-stage ventures in the healthcare industry and provide financial backing, strategic guidance, and operational support to drive transformative change and long-term success for their portfolio companies.Latest News
Powered by
May 14, 2024: Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Brixton Biosciences , a spin-out from Massachusetts General Brigham and a clinical stage life sciences company developing novel therapies for chronic and acute pain, today announced that it closed a Series B funding round of $33M . The round was led by Schooner Capital with notable participation by SV Health Investors , Sparta Group , Excelestar Ventures , PV Capital Management , and Catalyst Health Ventures .
Jul 12, 2023: CarePredict Receives Series A-3 Funding to Accelerate Growth in Senior Care
CarePredict today announced a $29M Series A-3 investment co-led by SV Health Investors' Medtech Convergence Fund and Aspire Healthtech Partners. CarePredict's innovative technology autonomously identifies changes in daily activity and behaviors that precede health issues such as urinary tract infections, falls, malnutrition and depression. The ability to detect the early signs of health concerns allows preventive care and preserves the overall wellbeing of older adults. Peer-reviewed and published studies have shown that CarePredict reduces hospitalizations by 39%, falls by 69% and increases the length of stay in a lower care setting by 67%.
Jun 26, 2023: SV Health Investors Completes Partnership with Packaging Compliance Labs
SV Health Investors ("SVHI"), a Boston -based private investment firm focused exclusively on the healthcare industry, announced today an investment in Packaging Compliance Labs ("PCL"). Headquartered in Grand Rapids, MI , Packaging Compliance Labs is a provider of healthcare packaging engineering, validation testing, and contract packaging services to medical device and pharmaceutical end markets. PCL represents a new platform investment for SV Health Investors, in partnership with Co-Founders Matthew Lapham and Ryan Erickson .
Jun 20, 2023: SV Health Investors Acquires Robling Medical
SV Health Investors ("SVHI"), a Boston -based private investment firm focused exclusively on the healthcare industry, announced today the acquisition of a controlling interest in Robling Medical ("Robling"). Headquartered in Youngsville, NC , Robling Medical is a full-service outsourced manufacturing partner to the medical device and pharmaceutical industries. Robling represents a new platform investment for SV Health Investors, building on SVHI's growing efforts in the outsourced medtech services sector.
Jun 13, 2023: LSI USA Emerging Medtech Summit Returns to Dana Point March 18, 2024
LSI, the company behind LSI Emerging Medtech Summits, the partnering events for global leaders building breakthrough healthcare businesses, today announced it will host its next USA Emerging Medtech Summit, LSI USA '24, on March 18 through 22 at the Monarch Beach Resort, Waldorf Astoria in Dana Point, California .